Market Place
Sourcing Support
All News #Library
Others
Noven Debuts ADHD Mindful Patch Companion App at APSARD 2025
14 Jan 2025 //
BUSINESSWIRE
XELSTRYM transdermal system, CII, to be revealed as available soon at APSARD
10 Jan 2023 //
PR NEWSWIRE
Noven To Participate In Annual International Conference On Adhd (Chadd)
10 Nov 2022 //
PRNEWSWIRE
Noven To Present Poster Data At The AACAP & CACAP Conference
11 Oct 2022 //
PRNEWSWIRE
Noven to Present Pivotal Study Results for Investigational Dextroamphetamine
27 Apr 2021 //
BUSINESSWIRE
Noven Submits New Drug Application for Investigational Dextroamphetamine
22 Feb 2021 //
BUSINESSWIRE
Noven Submits New Drug Application for Investigational Dextroamphetamine
22 Feb 2021 //
BUSINESSWIRE
SECUADO® (asenapine) Transdermal System, the First-and-Only Transdermal Patch
13 Apr 2020 //
BUSINESSWIRE
FDA Approves Noven Pharmaceuticals’ Transdermal Patch for Schizophrenia
15 Oct 2019 //
BIOSPACE
Categorical Response &Clinical Relevance as Assessed in a PhIII Study of HP-3070
20 May 2019 //
BUSINESSWIRE
Patent:Novartis AG v. Noven Pharmaceuticals Inc.
05 Apr 2017 //
PATENT DOC
Up and Down the Ladder: The Latest Comings & Goings at Orexigen, Pfizer and…
04 Apr 2015 //
PHARMALOT
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.